Recent Patents on Anti-Cancer Drug Discovery

Back

Become EABM
Become Reviewer

Most Cited Article

PARP Inhibitors in Ovarian Cancer

Volume:13   Issue:4
Pp: 392-410
Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*
DOI: 10.2174/1574892813666180305165256

Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy open access plus

Volume:13   Issue:1
Pp: 86-105
Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*
DOI: 10.2174/1574892812666171108124218

Advances in the Discovery of Anthraquinone-Based Anticancer Agents

Volume:13   Issue:2
Pp: 159-183
Alexander S. Tikhomirov*, Alexander A. Shtil and Andrey E. Shchekotikhin
DOI: 10.2174/1574892813666171206123114

The Application of lncRNAs in Cancer Treatment and Diagnosis

Volume:13   Issue:3
Pp: 292-301
Yi Zhang and Liling Tang*
DOI: 10.2174/1574892813666180226121819

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins open access plus

Volume:13   Issue:2
Pp: 184-200
Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*
DOI: 10.2174/1574892812666171129141211

PARP Inhibitors in Epithelial Ovarian Cancer open access plus

Volume:13   Issue:2
Pp: 145-158
Kristin N. Taylor and Ramez N. Eskander*
DOI: 10.2174/1574892813666171204094822

Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature

Volume:13   Issue:1
Pp: 40-69
Joana B. Sousa, Paula Fresco, Carmen Diniz* and Jorge Goncalves
DOI: 10.2174/1574892812666171108115959

Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy open access plus

Volume:13   Issue:1
Pp: 2-17
Sandra Iurescia*, Daniela Fioretti and Monica Rinaldi*
DOI: 10.2174/1574892812666171030163804

Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents

Volume:14   Issue:2
Pp: 113-132
Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*
DOI: 10.2174/1574892814666190514104035

Anti-Oxidants as Chemopreventive Agents in Prostate Cancer: A Gap Between Preclinical and Clinical Studies

Volume:13   Issue:2
Pp: 224-239
Monireh Mohsenzadegan*, Farhad Seif, Mohammad M. Farajollahi and Majid Khoshmirsafa
DOI: 10.2174/1574892813666180213164700

Recent Progress of Marine Polypeptides as Anticancer Agents

Volume:13   Issue:4
Pp: 445-454
Lanhong Zheng, Yixin Xu, Xiukun Lin*, Zhixin Yuan, Minghua Liu, Shousong Cao, Fuming Zhang and Robert J. Linhardt
DOI: 10.2174/1574892813666180430110033

NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents

Volume:13   Issue:1
Pp: 106-117
Spandana R. Kopalli , Tae-Bong Kang , Kwang-Ho Lee and Sushruta Koppula*
DOI: 10.2174/1574892812666171027102627

New Anti-Cancer Strategies in Testicular Germ Cell Tumors open access plus

Volume:14   Issue:1
Pp: 53-59
Paolo Chieffi*, Marco De Martino and Francesco Esposito
DOI: 10.2174/1574892814666190111120023

Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied open access plus

Volume:13   Issue:2
Pp: 201-208
Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi
DOI: 10.2174/1574892813666180220110729

Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents open access plus

Volume:14   Issue:1
Pp: 5-18
Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*
DOI: 10.2174/1574892814666190116111827

Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment open access plus

Volume:14   Issue:1
Pp: 32-38
Giorgia Scarpellino, Tullio Genova and Luca Munaron*
DOI: 10.2174/1574892814666190116122256

Low Dose of Acacetin Promotes Breast Cancer MCF-7 Cells Proliferation Through the Activation of ERK/ PI3K /AKT and Cyclin Signaling Pathway

Volume:13   Issue:3
Pp: 368-377
Huanhuan Ren, Jun Ma, Lingling Si, Boxue Ren, Xiaoyu Chen, Dan Wang, Wenjin Hao, Xuexi Tang, Defang Li* and Qiusheng Zheng*
DOI: 10.2174/1574892813666180420154012

Synthesis and DFT Study on Hantzsch Reaction to Produce Asymmetrical Compounds of 1,4-Dihydropyridine Derivatives for P-Glycoprotein Inhibition as Anticancer Agent

Volume:13   Issue:2
Pp: 255-264
Shirin Mollazadeh, Fatemeh Moosavi, Farzin Hadizadeh*, Mahmoud Seifi, Javad Behravan and Maryam Iman*
DOI: 10.2174/1574892813666180220112613

Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation open access plus

Volume:13   Issue:2
Pp: 133-144
Juan F. Santibanez* and Suncica Bjelica
DOI: 10.2174/1574892813666180220105958

Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer’s Disease open access plus

Volume:14   Issue:2
Pp: 144-157
Dongmei Chen, Xiao Z. Zhou* and Tae H. Lee*
DOI: 10.2174/1574892814666181218170257

Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds open access plus

Volume:14   Issue:1
Pp: 19-31
Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*
DOI: 10.2174/1574892814666190111104834